2-methylbut-3-enoic acid

We are 2-methylbut-3-enoic acid CAS:53774-20-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 53774-20-2
Product Name: 2-methylbut-3-enoic acid
Other Name:
2-methylbut-3-enoic acid
2-methyl-3-butenenoic acid
2-vinyl propionic acid
2-methyl-3-butenoic acid
 
Density: 0.968 g/mL at 20ºC
Boiling Point: 42-43ºC/0.1 mmHg(lit.)
Molecular Formula: C5H8O2
Molecular Weight: 100.11600
Flash Point: 76ºC
Exact Mass: 100.05200
PSA: 37.30000
LogP: 0.89310
Index of Refraction: n20/D 1.424
 
Specification
Appearance: Colorless transparent liquid
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-methylbut-3-enoic acid


Related News: We manufacture APIs and drug manufacturers make medicines from APIs.2-bromo-5-fluoro-6-metilpiridina CAS:374633-38-2 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid CAS:112984-60-8 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.5-Amino-2,3-dihydrobenzofuran CAS:42933-43-7 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.

Related Products
Product Name
Tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate View Details
Mesitaldehyde View Details
dimethicone macromolecule View Details
3-Bromo-2-Fluoroaniline manufacturer (S)-2,5-Bis(((benzyloxy)carbonyl)-amino)pentanoic acid manufacturer 4,5-Difluoro-2-Iodobenzoic Acid manufacturer 5-Bromo-2-hydroxybenzonitrile manufacturer Methyl 5-Formyl-2-methoxybenzoate manufacturer